Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 752 Jan 1 – Oct 25, 2026
- Disclosed funding
- $25.9B 611 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| RH Rapalogix HealthCompany profile Develops prescription therapeutics and skincare products for cellular longevity and skin health Develops prescription therapeutics and skincare products for cellular longevity and skin health | $20M | Series A | Healthtech, Biotech | United States | Investors | |
| C Automates chronic care for older adults using AI | $100M | Series CSeries C+ | Healthtech | United States | Investors | |
| NB NorthLinks BioCompany profile Develops broad-spectrum antiviral prophylactic therapies for respiratory infections Develops broad-spectrum antiviral prophylactic therapies for respiratory infections | $34M | Undisclosed | Healthtech, Biotech | United States | Investors | |
| OB Osanni BioCompany profile Platform that discovers and de-risks novel drug programs in ophthalmology and cardiology via affiliate company model Platform that discovers and de-risks novel drug programs in ophthalmology and cardiology via affiliate company model | $190M | Series B | Healthtech, Biotech | United States | Investors | |
| AS Astral SystemsCompany profile Develops multi-state fusion technology for medical radioisotopes and commercial applications Develops multi-state fusion technology for medical radioisotopes and commercial applications | £23M | Series A | Healthtech, Industrial tech | United Kingdom | Investors | |
| LH Ladder HealthCompany profile Delivers virtual-first AI-enabled pediatric developmental and therapeutic care for children and families Delivers virtual-first AI-enabled pediatric developmental and therapeutic care for children and families | $7M | Seed | Healthtech | United States | Investors | |
 Bionyra PharmaCompany profile Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases. Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases. | $165M | Series A | Healthtech, Biotech | France | Investors | |
| H HistoSonicsCompany profile Develops non-invasive histotripsy platform using focused ultrasound to mechanically destroy tumors without surgery Develops non-invasive histotripsy platform using focused ultrasound to mechanically destroy tumors without surgery | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors | |
| LT Lys TherapeuticsCompany profile Develops monoclonal antibody LYS241 targeting neurovascular pathways for Parkinson's disease and stroke Develops monoclonal antibody LYS241 targeting neurovascular pathways for Parkinson's disease and stroke | >€25M | Seed | Healthtech, Biotech | France | Investors | |
| PA Prosper AICompany profile Automates the patient journey from scheduling and insurance to billing and collections Automates the patient journey from scheduling and insurance to billing and collections | $30M | Series A | Healthtech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.